MRSA in hospital children: studying antibiotics and nose bacteria
Part of Infections clinical trials.
This study looks at how antibiotics affect MRSA (a type of staph infection) in the noses of hospitalized children. It may help doctors better understand MRSA to improve treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 1 and 16 years old.
- Your child must be staying in the hospital.
- Your child does not have cancer or a blood disorder.
- Your child is not in the Pediatric Intensive Care Unit (PICU).
- You (parent or legal guardian) must sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the bacteria in the nose and throat of children and young adults who have a respiratory infection. It aims to understand how these bacteria might affect the infection and recovery.
This study looks at bacteria (especially pneumococcus) in the nose and throat of children. It includes children with ear infections or healthy children, to understand which germs are carried and how they relate to illness.
This study tests whether giving a nasal spray of healthy bacteria to infants can restore good germs in the nose after they receive mupirocin ointment to treat Staph aureus. It aims to bring back a healthy nasal microbiome.
This trial studies the bacteria living in the nose of patients with a staph bloodstream infection. It aims to better understand why some infections persist, which could lead to better treatments.
This study looks at the germ Staphylococcus aureus in newborns in the neonatal intensive care unit (NICU). It aims to track how the germ spreads and understand its genes, which could help keep other babies safe.
This trial tests a new nose spray called HY-133 to see if it's safe and can clear a common type of staph bacteria from the nose. It is for people who have this bacteria but not the antibiotic-resistant kind.
Hear when a new NAsal MEthicillin-resistant Staphylococcus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.